Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey

Wambui G. Gathirua-Mwangi, Patrick Monahan, Mwangi J. Murage, Jianjun Zhang 

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question. Methods: A total of 687 cancer deaths were identified from 14,916 participants in the third National Health and Nutrition Examination Survey by linking them to the National Death Index database through December 31, 2006. Cox proportional hazards regression was performed to calculate hazard ratios (HR) and 95% confidence intervals (CI) for total cancer mortality in relation to metabolic syndrome and its individual components. Results: After adjustment for confounders, a diagnosis of metabolic syndrome was associated with 33% elevated total cancer mortality. Compared with individuals without metabolic syndrome, those with 3, 4 and 5 abnormal components had HRs (95% CIs) of 1.28 (1.03–1.59), 1.24 (0.96–1.60), and 1.87 (1.34–2.63), respectively (p-trend = 0.0003). Systolic blood pressure and serum glucose were associated with an increased risk of death from total cancer [HR (95% CI) for highest vs. lowest quartiles: 1.67 (1.19–2.33), p-trend = 0.002 and 1.34 (1.04–1.74), p-trend = 0.003, respectively]. Overall null results were obtained for lung cancer mortality. The effects of metabolic syndrome and its components on non-lung cancer mortality were generally similar to, but somewhat larger than, those for total cancer mortality. Conclusion: Our study is among the first to reveal that metabolic syndrome is associated with increased total cancer mortality.

Original languageEnglish (US)
Pages (from-to)127-136
Number of pages10
JournalCancer Causes and Control
Volume28
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Nutrition Surveys
Mortality
Neoplasms
Confidence Intervals
Blood Pressure
Lung Neoplasms
Databases
Glucose
Incidence
Serum

Keywords

  • Epidemiology
  • Lung cancer mortality
  • Metabolic syndrome
  • Non-lung cancer mortality, cohort study
  • Obesity
  • Total cancer mortality

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey. / Gathirua-Mwangi, Wambui G.; Monahan, Patrick; Murage, Mwangi J.; Zhang , Jianjun.

In: Cancer Causes and Control, Vol. 28, No. 2, 01.02.2017, p. 127-136.

Research output: Contribution to journalArticle

@article{5036cda5051844a395a30f2981a7ed7e,
title = "Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey",
abstract = "Purpose: Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question. Methods: A total of 687 cancer deaths were identified from 14,916 participants in the third National Health and Nutrition Examination Survey by linking them to the National Death Index database through December 31, 2006. Cox proportional hazards regression was performed to calculate hazard ratios (HR) and 95{\%} confidence intervals (CI) for total cancer mortality in relation to metabolic syndrome and its individual components. Results: After adjustment for confounders, a diagnosis of metabolic syndrome was associated with 33{\%} elevated total cancer mortality. Compared with individuals without metabolic syndrome, those with 3, 4 and 5 abnormal components had HRs (95{\%} CIs) of 1.28 (1.03–1.59), 1.24 (0.96–1.60), and 1.87 (1.34–2.63), respectively (p-trend = 0.0003). Systolic blood pressure and serum glucose were associated with an increased risk of death from total cancer [HR (95{\%} CI) for highest vs. lowest quartiles: 1.67 (1.19–2.33), p-trend = 0.002 and 1.34 (1.04–1.74), p-trend = 0.003, respectively]. Overall null results were obtained for lung cancer mortality. The effects of metabolic syndrome and its components on non-lung cancer mortality were generally similar to, but somewhat larger than, those for total cancer mortality. Conclusion: Our study is among the first to reveal that metabolic syndrome is associated with increased total cancer mortality.",
keywords = "Epidemiology, Lung cancer mortality, Metabolic syndrome, Non-lung cancer mortality, cohort study, Obesity, Total cancer mortality",
author = "Gathirua-Mwangi, {Wambui G.} and Patrick Monahan and Murage, {Mwangi J.} and Jianjun Zhang ",
year = "2017",
month = "2",
day = "1",
doi = "10.1007/s10552-016-0843-1",
language = "English (US)",
volume = "28",
pages = "127--136",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey

AU - Gathirua-Mwangi, Wambui G.

AU - Monahan, Patrick

AU - Murage, Mwangi J.

AU - Zhang , Jianjun

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Purpose: Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question. Methods: A total of 687 cancer deaths were identified from 14,916 participants in the third National Health and Nutrition Examination Survey by linking them to the National Death Index database through December 31, 2006. Cox proportional hazards regression was performed to calculate hazard ratios (HR) and 95% confidence intervals (CI) for total cancer mortality in relation to metabolic syndrome and its individual components. Results: After adjustment for confounders, a diagnosis of metabolic syndrome was associated with 33% elevated total cancer mortality. Compared with individuals without metabolic syndrome, those with 3, 4 and 5 abnormal components had HRs (95% CIs) of 1.28 (1.03–1.59), 1.24 (0.96–1.60), and 1.87 (1.34–2.63), respectively (p-trend = 0.0003). Systolic blood pressure and serum glucose were associated with an increased risk of death from total cancer [HR (95% CI) for highest vs. lowest quartiles: 1.67 (1.19–2.33), p-trend = 0.002 and 1.34 (1.04–1.74), p-trend = 0.003, respectively]. Overall null results were obtained for lung cancer mortality. The effects of metabolic syndrome and its components on non-lung cancer mortality were generally similar to, but somewhat larger than, those for total cancer mortality. Conclusion: Our study is among the first to reveal that metabolic syndrome is associated with increased total cancer mortality.

AB - Purpose: Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question. Methods: A total of 687 cancer deaths were identified from 14,916 participants in the third National Health and Nutrition Examination Survey by linking them to the National Death Index database through December 31, 2006. Cox proportional hazards regression was performed to calculate hazard ratios (HR) and 95% confidence intervals (CI) for total cancer mortality in relation to metabolic syndrome and its individual components. Results: After adjustment for confounders, a diagnosis of metabolic syndrome was associated with 33% elevated total cancer mortality. Compared with individuals without metabolic syndrome, those with 3, 4 and 5 abnormal components had HRs (95% CIs) of 1.28 (1.03–1.59), 1.24 (0.96–1.60), and 1.87 (1.34–2.63), respectively (p-trend = 0.0003). Systolic blood pressure and serum glucose were associated with an increased risk of death from total cancer [HR (95% CI) for highest vs. lowest quartiles: 1.67 (1.19–2.33), p-trend = 0.002 and 1.34 (1.04–1.74), p-trend = 0.003, respectively]. Overall null results were obtained for lung cancer mortality. The effects of metabolic syndrome and its components on non-lung cancer mortality were generally similar to, but somewhat larger than, those for total cancer mortality. Conclusion: Our study is among the first to reveal that metabolic syndrome is associated with increased total cancer mortality.

KW - Epidemiology

KW - Lung cancer mortality

KW - Metabolic syndrome

KW - Non-lung cancer mortality, cohort study

KW - Obesity

KW - Total cancer mortality

UR - http://www.scopus.com/inward/record.url?scp=85009727749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009727749&partnerID=8YFLogxK

U2 - 10.1007/s10552-016-0843-1

DO - 10.1007/s10552-016-0843-1

M3 - Article

C2 - 28097473

AN - SCOPUS:85009727749

VL - 28

SP - 127

EP - 136

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 2

ER -